Expression of Interest for Pharmaceutical Products

Closing date for receipt of REoI:  Multiple windows of submissions due on 1st day of every month open for 12 month starts on 1st July 2025 and ends on 1st May 2026.

There are multiple due dates for submission: 1st of July 2025, 1st Aug 2025, 1st Sep 2025, 1st Oct 2025, 1st Nov 2025, 1st Dec 2025, 1st Jan 2026, 1st Feb 2026, 1st Mar 2026, 1st April 2026, 1st May 2026 and final due date 1st June 2026.

UNICEF, Afghanistan Country Office, Kabul, Afghanistan is requesting Expressions of Interest from potential suppliers of pharmaceuticals from Afghanistan and its neighbouring countries (India, Iran, Pakistan, China, etc.) in preparation for a solicitation exercise for pharmaceutical products.

Interested suppliers or manufacturers of pharmaceuticals, please read below the requirements and submit your expression of interest (EoI) by filling in the forms along with the documentation requested.

This REoI is addressed to suppliers and manufacturers of pharmaceuticals in the region for the supply of any of the listed pharmaceutical products.

6  Amoxicillin powder for oral suspension, 250mg /5ml (anhydrous)

7  Ampicillin 1g (as sodium salt) powder for injection

9  Betamethasone 0.1% + Neomycine 0.5%, topical cream

10  Ceftriaxone powder for injection/infusion 500mg

17  Erythromycin (Ethyl succinate) Suspension 100 mg/ml, bottles

25  Lidocaine (hydrochloride) 1% + Adrenaline (epinephrine) 1:200 000, injection

26  Lidocaine (hydrochloride) 2% + Adrenaline (epinephrine) 1:200 000, injection

38  Phenoxymethylpenicillin (Penicillin V) 500mg (as potassium-salt), tablet

39  Phenoxymethylpenicillin (Penicillin V) 250mg (as potassium-salt), tablet

43  Salbutamol inhalation (aerosol) 0.1 mg (sulfate) per dose, 200 doses/inhaler

44  Sodium Chloride 0.9 % w/v and Glucose 5% w/v solution

For an itemised list of products per category, please refer to the accompanying Expression of